mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |